In the latest episode of Health Futures Taking Stock in You, host Bob Roth sat down with Dr. Michael Gordon, Chief Medical Officer at HonorHealth Research Institute, for an insightful discussion about patient-centered care, clinical research, and the future of cancer treatment in Arizona. Dr. Gordon’s remarkable career and personal journey have shaped his approach to oncology, making his perspective invaluable in today’s evolving medical landscape.
For the full episode, CLICK HERE.
You can also find this on any of the following podcasts:
A Distinguished Career in Oncology
Dr. Gordon’s journey in medicine began in New York City, where he attended Stuyvesant High School before pursuing his medical degree at SUNY Buffalo. His training continued at the University of Chicago, followed by a fellowship at Memorial Sloan Kettering. He later served on the faculty at Indiana University before making Arizona his home 25 years ago. His contributions to the field of oncology have been widely recognized, culminating in his recent designation as a Fellow of the American Society of Clinical Oncology—an honor that reflects his lifelong dedication to cancer research and patient care.
From Doctor to Patient: A Transformative Experience
One of the most profound moments of the interview came when Dr. Gordon shared his own battle with pancreatic cancer. Experiencing the disease firsthand transformed his approach to patient care, instilling a renewed sense of urgency when making treatment decisions. His transition from oncologist to patient and back again gave him a deeper understanding of the emotional and physical toll cancer takes, strengthening his resolve to advocate for more compassionate, patient-centered care.
HonorHealth Research Institute’s Role in Clinical Trials and COVID-19 Response
Under Dr. Gordon’s leadership, the HonorHealth Research Institute played a pivotal role in advancing clinical research, particularly during the COVID-19 pandemic. His team quickly mobilized to launch nearly a dozen clinical trials, applying their expertise in cancer research to investigate potential treatments for the virus. Their work gained national recognition, with findings published in esteemed medical journals like the New England Journal of Medicine.
The Future of Cancer Treatment
Looking ahead, Dr. Gordon highlighted several groundbreaking developments shaping the future of oncology. Advances in artificial intelligence and machine learning are revolutionizing cancer diagnostics, enabling earlier and more accurate detection. Personalized treatment approaches, tailored to the unique genetic and biological characteristics of each patient, are becoming more prevalent, improving outcomes and reducing side effects. Additionally, emerging research suggests that GLP-1 agonists, commonly used for diabetes and weight management, may help reduce cancer risk by improving metabolic health.
Another concerning trend he addressed is the rise of colorectal cancer in young adults. By 2030, this form of cancer is expected to become the most prevalent among individuals aged 18 to 36. The increasing incidence underscores the need for greater awareness, early screenings, and proactive lifestyle changes to mitigate risk.
Prevention and Wellness: A Holistic Approach
Dr. Gordon underscored the critical role of prevention and wellness in reducing cancer incidence. Routine cancer screenings, lifestyle modifications, and nutritional awareness can significantly impact overall health. Exercise programs and early intervention strategies also play a key role in mitigating risk factors and enhancing long-term outcomes. His message reinforced the idea that cancer care extends beyond treatment—it requires a proactive, holistic approach to wellness.
Arizona’s Expanding Medical Landscape
Arizona’s medical sector continues to grow, positioning the state as a hub for cutting-edge research and advanced treatment options. The expansion of HonorHealth’s facilities, the establishment of new medical schools, and the development of innovative research programs are driving progress in healthcare. Notably, the creation of the HonorHealth Cancer Care Network is enhancing access to specialized oncology services, ensuring that patients across the region receive top-tier care.
Looking Forward
With HonorHealth preparing to partner with Arizona State University’s newly established School of Medicine and Advanced Medical Engineering, the future of cancer care in Arizona is poised for transformation. Dr. Gordon remains committed to pioneering advancements in clinical research, medical education, and patient-centered care. His unwavering dedication to innovation and compassionate treatment continues to shape the field of oncology, offering hope for patients and families navigating cancer diagnoses.
For those interested in learning more about HonorHealth’s research initiatives or cancer care programs, visit their website or tune in to Health Futures Taking Stock in You, airing every Friday at noon on Money Radio 1510AM and 105.3FM.
